期刊文献+

替格瑞洛的合成工艺优化 被引量:2

Improved Synthesis of Ticagrelor
原文传递
导出
摘要 本研究对替格瑞洛的合成工艺进行了优化。4,6-二氯-5-氨基-2-丙硫基嘧啶(2)与2-[[(3aR,4S,6R,6aS)-6-氨基-2,2-二甲基四氢-4H-环戊二烯并[d][1,3]二氧杂环戊-4-基]氧基]-1-乙醇以N,N-二异丙基乙胺为缚酸剂于100℃反应得2-[[(3aR,4S,6R,6aS)-6-[[5-氨基-6-氯-2-(丙硫基)-4-嘧啶基]氨基]-2,2-二甲基四氢-4H-环戊二烯并[d][1,3]二氧杂环戊-4-基]氧基]-1-乙醇,收率87.1%;通过"一锅法"使重氮化环合反应和脱保护反应同时进行制得(1S,2S,3R,5S)-3-[7-氯-5-(丙硫基)-3H-[1,2,3]三唑[4,5-d]嘧啶-3-基]-5-(2-羟乙氧基)环戊烷-1,2-二醇,再与(1R,2S)-2-(3,4-二氟苯基)-环丙胺经氨基化得目标化合物。优化后的工艺缩减了反应步骤,简化了实验操作,总收率由文献的32.3%提高至61.8%(以2计)。 The synthetic process of ticagrelor was improved. 2- [[(3aR,4S,6R,6aS) -6- E E5-Amino-6-chloro-2- (propylthio)pyrimidin-4-yl]amino]-2,2-dimethyltetrahydro-4H-cyclopenta[d] E1,3]dioxol-4-yl]oxy]ethan-1-ol (4) was synthesized via nucleophilic substitution of 4,6-dichloro-5-amino-2-propylthiopyrimidine (2) and 2-[ [(3aR,4S,6R,6aS)- 6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d] [1,31dioxol-4-yl]oxy]ethan-l-ol in the presence of N, N- diisopropylethylamine at 100℃ with a yield of 87.1%. Then compound 4 was converted to (1S,2S,3R,5S)-3-E7-chloro- 5- (propylthio) -3 H- [1,2,31 triazolo [4,5-d] pyrimidin-3-yl]-5- (2-hydroxyethoxy) cyclopentane- 1,2-diol by "one-pot" reaction (diazo-cyclization and deprotection) with a yield of 83.5%. Then the latter was subjected to amination with (1R,2S)-2-(3,4-difluorophenyl) cyclopropan-1-amine to provide the target compound. This improved synthetic route had less reaction steps and simplified operation procedures, and also gave a better overall yield of 61.8 % (based on 2).
作者 孙兰天 王业明 闫红 SUN Lantian;WANG Yeming;YAN Hong(College of Life Science and Bio-engineering, Beijing University of Technology, Beijing 100124)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2018年第4期445-449,共5页 Chinese Journal of Pharmaceuticals
关键词 替格瑞洛 4 6-二氯-5-氨基-2-丙硫基嘧啶 工艺优化 “一锅法” ticagrelor 4,6-dichloro-5-amino-2-propylthiopyrimidine process optimization "one-pot" method
  • 相关文献

参考文献1

二级参考文献9

  • 1Simon. The invention provides new triazolo [ 4,5-d ] py- rimidine compounds of formula (I) , their use as medic- aments, compositions containing them and processes for their preparation:WO 990143 [ P]. 1999.
  • 2Ulf Larsson, Magnusson, Musil, et al. Novel triazolo pyrimidine compounds : US 20030148888 [ P]. 2003.
  • 3Anil S K, Vignesh N, Nikhil T. Improved process for preparing eyelopentylamine derivatives and intermedi-ates thereof: WO 2012172426 [ P 3. 2012.
  • 4David H, Anthony I, Brian S, et al. Triazolo (4,5-D) pyrimi- dine : US 6525060 E P]. 2003.
  • 5Zhang H, lJu J, Zhang L Y, et a/. Synthesis and biological e- valuation of cyclopentyl-triazolo- pyrimidine derivatives as novel antiplatelet agents[ J ]. Bioorgan- ic & Medicinal Chemistry Let- ters,2012,~'~( 11 ) :3598 - 3602.
  • 6胡晨阳,任芳俊,盛晓霞,等.替格瑞洛晶型及其制备方法和用途:CN201310118496.8[P].2013.
  • 7M·博林,S·科斯格洛夫,B·拉森.三唑并[4,5.D]嘧啶化合物的新晶形和非晶形:CN01810582.3[P].2001.
  • 8曾志旋,曹胜华,陈林,李江红,石克金,丁小东.替格瑞洛的合成工艺改进[J].化学研究与应用,2015,27(3):373-377. 被引量:2
  • 9缪世峰,蔺宇,张海波,梁慧兴,陈令武.新型抗凝血药替格瑞洛的合成[J].海峡药学,2015,27(4):249-251. 被引量:10

共引文献8

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部